Norco and Affect lability - a phase IV clinical study of FDA data
Summary:
Affect lability is reported as a side effect among people who take Norco (acetaminophen; hydrocodone bitartrate), especially for people who are female, 40-49 old, also take Cymbalta, and have Depression.
The phase IV clinical study analyzes which people have Affect lability when taking Norco. It is created by eHealthMe based on reports of 71,619 people who have side effects when taking Norco from the FDA, and is updated regularly.
What is Norco?
Norco has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 74,060 Norco users. Check the latest studies of Norco.
What is Affect lability?
Affect lability (emotional incontinence) is found to be associated with 772 drugs and 813 conditions by eHealthMe. Check the latest studies of Affect lability.
71,619 people reported to have side effects when taking Norco.
Among them, 51 people (0.07%) have Affect lability.

Among these 51 people:
What is the gender of people who have Affect lability when taking Norco? *
What is the age of people who have Affect lability when taking Norco? *
What are other drugs people take besides Norco? *
What are other side effects people have besides Affect lability? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Norco and have Affect lability?
- Check whether Affect lability is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Norco:
- Norco (74,060 reports)
Affect lability treatments and more:
- Affect lability (13,491 reports)
How severe was Affect lability and when was it recovered:
Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Norco side effects:
- Norco side effect: Death (11,511 reports)
- Norco side effect: Drug dependence (5,161 reports)
Browse all side effects of Norco:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Affect lability:
- Cymbalta side effect: Affect lability (2,752 reports)
- Metformin side effect: Affect lability (529 reports)
- Aspirin side effect: Affect lability (412 reports)
- Amlodipine side effect: Affect lability (403 reports)
- Methotrexate side effect: Affect lability (394 reports)
- Lipitor side effect: Affect lability (383 reports)
- Irbesartan side effect: Affect lability (352 reports)
- Januvia side effect: Affect lability (349 reports)
- Avapro side effect: Affect lability (314 reports)
- Prednisone side effect: Affect lability (298 reports)
Browse all the drugs that are associated with Affect lability:
- Affect lability (772 drugs)
Common conditions associated with Affect lability:
- Depression: 1,410 reports
- Pain: 839 reports
- Alternative medicine - pain relief: 824 reports
- Hypertension: 577 reports
- High blood pressure: 576 reports
- Tension: 476 reports
- Ms: 451 reports
- Childhood hyperkinesis: 379 reports
- Contraception: 359 reports
- Birth control: 251 reports
Browse all the conditions that are associated with Affect lability:
- Affect lability (813 conditions)
Drugs similar to Norco and Affect lability :
- Acetaminophen side effect: Affect lability
- Advil side effect: Affect lability
- Aleve side effect: Affect lability
- Amitriptyline hydrochloride side effect: Affect lability
- Aspirin side effect: Affect lability
- Celebrex side effect: Affect lability
- Codeine side effect: Affect lability
- Cymbalta side effect: Affect lability
- Darvocet side effect: Affect lability
- Darvocet-n 100 side effect: Affect lability
- Dilaudid side effect: Affect lability
- Flexeril side effect: Affect lability
- Gabapentin side effect: Affect lability
- Hydromorphone hydrochloride side effect: Affect lability
- Ibu side effect: Affect lability
- Ibuprofen side effect: Affect lability
- Lyrica side effect: Affect lability
- Meloxicam side effect: Affect lability
- Methadone hydrochloride side effect: Affect lability
- Morphine side effect: Affect lability
- Morphine sulfate side effect: Affect lability
- Motrin side effect: Affect lability
- Naproxen side effect: Affect lability
- Neurontin side effect: Affect lability
- Oxycodone side effect: Affect lability
- Oxycodone and acetaminophen side effect: Affect lability
- Oxycodone hydrochloride side effect: Affect lability
- Oxycontin side effect: Affect lability
- Paracetamol side effect: Affect lability
- Percocet side effect: Affect lability
- Profen side effect: Affect lability
- Suboxone side effect: Affect lability
- Tramadol side effect: Affect lability
- Tramadol hydrochloride side effect: Affect lability
- Tylenol side effect: Affect lability
- Tylenol w/ codeine side effect: Affect lability
- Tylenol w/ codeine no. 3 side effect: Affect lability
- Ultram side effect: Affect lability
How the study uses the data?
The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Norco) and Norco (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Humalog cause Conjunctivitis Allergic? - 3 seconds ago
- Could Gemfibrozil cause Hernia? - 3 seconds ago
- Vasculitis and drugs of ingredients of gemfibrozil - 5 seconds ago
- Drug interactions of Nexium and Levocetirizine Dihydrochloride - 8 seconds ago
- Celecoxib and Taxol drug interactions for women aged 60+ - 9 seconds ago
- Miralax and Appetite - Decreased for Women aged 60+ - 11 seconds ago
- Miralax and Appetite Decreased for Women aged 60+ - 11 seconds ago
- Miralax and Reduced Appetite for Women aged 60+ - 11 seconds ago
- Miralax and Decreased Appetite for Women aged 60+ - 12 seconds ago
- Miralax and Loss Of Appetite for Women aged 60+ - 12 seconds ago